BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5511783)

  • 1. Occurrence of an abnormal lipoprotein in patients with liver disease.
    Ross A; Murphy GM; Wilkinson PA; Mills GL; Sherlock S
    Gut; 1970 Dec; 11(12):1035-7. PubMed ID: 5511783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of lipoprotein X in the diagnosis of obstructive jaundice: comparison with other biochemical tests (author's transl)].
    Mayr K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2193-7. PubMed ID: 240665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-X (LP-X) in liver disease.
    Ritland S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(2):155-60. PubMed ID: 4697077
    [No Abstract]   [Full Text] [Related]  

  • 5. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the occurrence of lipoprotein-x in non-hemolytic jaundice.
    Samsioe G; Lundborg H; Ivarsson S; Gustafson A
    Acta Chir Scand; 1976; 142(3):187-90. PubMed ID: 180734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the abnormal lipoprotein-X in obstructive and non-obstructive jaundice.
    Vergani C; Pietrogrande M; Grondona MC
    Clin Chim Acta; 1973 Oct; 48(3):243-8. PubMed ID: 4797281
    [No Abstract]   [Full Text] [Related]  

  • 8. [An abnormal low density lipoprotein in cholestaris. II. Significance for the differential diagnosis of jaundice].
    Seidel D; Schmitt EA; Alaupovic P
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1805-9. PubMed ID: 5465694
    [No Abstract]   [Full Text] [Related]  

  • 9. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN; Alaupovic P
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and likely origins of serum particulate alkaline phosphatase and lipoprotein-X in liver disease.
    Brocklehurst D; Wilde CE; Doar JW
    Clin Chim Acta; 1978 Sep; 88(3):509-15. PubMed ID: 699340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in cholestasis of pregnancy.
    Johnson P; Samsioe G; Gustafson A
    Acta Obstet Gynecol Scand; 1975; 54(2):105-11. PubMed ID: 166548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of an abnormal lipoprotein (LP-X) associated with cholestasis].
    Vergani C; Pietrogrande M; Grondona MC; Pizzolato M
    Minerva Med; 1973 Apr; 64(28):1461-85. PubMed ID: 4196357
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biochemical indices of the blood serum in various liver diseases].
    Tokarskaia ZB; Chernova GV; Dorozhko VA
    Ter Arkh; 1974; 46(4):53-8. PubMed ID: 4139774
    [No Abstract]   [Full Text] [Related]  

  • 15. [LP-X in the first month of life (author's transl)].
    Lachmann D; Eder G
    Padiatr Padol; 1977; 12(4):334-8. PubMed ID: 904943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease.
    Tăpălagă D; Opincaru A; Cucuianu M
    Acta Hepatogastroenterol (Stuttg); 1979 Feb; 26(1):9-16. PubMed ID: 34311
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis.
    Miyahara K; Kasahara N; Kondo Y; Imai Y; Matuzaki F
    Jpn J Med; 1991; 30(4):354-9. PubMed ID: 1942649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein patterns in liver and heart disease.
    Papadopoulos NM; Bedynek JL
    Ann Clin Lab Sci (1971); 1972; 2(5):343-7. PubMed ID: 4343278
    [No Abstract]   [Full Text] [Related]  

  • 20. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.